-
Nigeria is working on COVID-19 vaccine, president says
FirstWordPharma
January 07, 2022
Nigeria's president says the country is working to develop a COVID-19 vaccine as it battles growing cases of the virus, as reported in the Financial Post.
-
No paracetamol, painkillers recommended after Covaxin jab: Bharat Biotech
ExpressPharma
January 07, 2022
No paracetamol or painkiller is recommended after being vaccinated with COVID-19 vaccine Covaxin, Bharat Biotech said yesterday.
-
Mobilising vaccine investments vital – leading macroeconomic influencers
Pharmaceutical-Technology
January 07, 2022
The world’s vaccine investment rate is as low as 25%, not enough to vaccinate the entire planet.
-
Pfizer and BioNTech enter deal to develop first mRNA vaccine for shingles
Pharmaceutical-Technology
January 07, 2022
Pfizer and BioNTech have entered a new research, development and marketing partnership for a potential first mRNA-based vaccine to prevent shingles (herpes zoster virus (HZV)).
-
Leiden University Medica Center and Intravacc to start clinical trial with new intranasal corona vaccine
ExpressPharma
January 06, 2022
Intravacc yesterday announced a partnership with Leiden University Medical Center (LUMC) to develop and evaluate a new nasal spray corona vaccine in a clinical phase-I/II study.
-
The C.D.C. now recommends that people stay ‘up to date’ with Covid vaccine boosters.
FirstWordPharma
January 06, 2022
The US Centers for Disease Control and Prevention (CDC) on Wednesday said it was not changing its definition of "full vaccination" against COVID-19, but the agency adjusted its emphasis on the appropriate regimen...
-
COVID-19 Oral Vaccine and Antibody Booster: B. subtilis Spores, Biotechnology Breakthrough by DreamTec
prnasia
January 05, 2022
Vaccines have been a trending topic ever since the coronavirus outbreak two years ago. DreamTec Research Limited (DreamTec, http://www.dreamtec.hk) has its major breakthrough in developing a COVID-19 oral vaccine.
-
CPhI Worldwide releases pharma market predictions for 2022
ExpressPharma
January 05, 2022
CPhI Worldwide has released its beginning of year pharma market predictions for 2022 combining research from more than 350 pharma executives and expert views from 10 CPhI contributors, as per a statement from CPhI.
-
Why we need an Aatmanirbhar booster strategy
ExpressPharma
January 04, 2022
A year ago, I asked if intellectual property rights (IPRs) could be part of the COVID-19 solution, rather than the problem.
-
Biological E aims to produce 100 million doses/month of Corbevax from Feb 2022
ExpressPharma
December 29, 2021
Biological E plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022...